PMV Pharmaceuticals PMVP
NASDAQ PMVP
$1.65 +0.23 (+15.73%)
As of: Sep 30, 2026 · 11:37 AM EDT

PMV Pharmaceuticals (PMVP) Operating Expenses (2019 - 2026)

Updated

PMV Pharmaceuticals (PMVP) reported Operating Expenses of $18.88 million for Q2 2026, down 17.5% from $22.88 million a year earlier and down 0.7% from the prior quarter.

Analysis

PMV Pharmaceuticals (PMVP) Operating Expenses (2019 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, PMV Pharmaceuticals' Operating Expenses came in at $79.66 million, down 12.9% year-over-year; for FY2025, it came in at $86.21 million, up 0.9% from FY2024.

  • Operating Expenses has increased for seven consecutive years, with a five-year compound annual growth rate of 19.8% (FY2020 to FY2025).
  • By year, Operating Expenses came in at $85.45 million in FY2024 (+6.6%), $80.13 million in FY2023 (+4.0%), $77.04 million in FY2022 (+32.2%) and $58.29 million in FY2021 (+66.8%).
  • The Q2 2026 figure ranks as the lowest quarterly Operating Expenses since Q1 2024.
  • Year over year, Operating Expenses has now declined in each of the last three quarters, with growth averaging 3.3% over the last eight quarters.
  • The high point for year-over-year Operating Expenses in five years was Q4 2021 (growth of 75.9%); the low point was Q4 2025 (a decline of 23.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $19.02 million (Q1 2026), $19.24 million (Q4 2025) and $22.52 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 PMV Pharmaceuticals 72.71 Mn -342.47 Mn - 18.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.88 Mn
Mar 31, 2026 19.02 Mn
Dec 31, 2025 19.24 Mn
Sep 30, 2025 22.52 Mn
Jun 30, 2025 22.88 Mn
Mar 31, 2025 21.56 Mn
Dec 31, 2024 25.17 Mn
Sep 30, 2024 21.89 Mn
Jun 30, 2024 20.17 Mn
Mar 31, 2024 18.22 Mn
Dec 31, 2023 18.90 Mn
Sep 30, 2023 19.63 Mn
Jun 30, 2023 20.12 Mn
Mar 31, 2023 21.48 Mn
Dec 31, 2022 21.16 Mn
Sep 30, 2022 19.38 Mn
Jun 30, 2022 17.89 Mn
Mar 31, 2022 18.62 Mn
Dec 31, 2021 18.47 Mn
Sep 30, 2021 15.10 Mn
API Access

PMV Pharmaceuticals Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=PMVP&period=max&api_key=YOUR_API_KEY